Dr Agarwal''s Health Care Q1 Profit
Aug 12, 2025 19:18
Dr Agarwal''s Health Care Ltd reports Rs 17.26 cr net profit for Q1 2025. Revenue growth, network expansion, and Delhi market entry highlighted.
Chennai, Aug 12 (PTI) Dr Agarwal's Health Care Ltd has reported a net profit of Rs 17.26 crore for the April-June 2025 quarter on the back of a robust performance, the eye care provider said on Tuesday.
The city-based firm earned a net profit of Rs 14.11 crore during the corresponding quarter of the last fiscal.
For the year ending March 31, 2025, the consolidated net profit was at Rs 54.65 crore, the company said in a press release here.
The total income for the quarter under review surged to Rs 117.72 crore, from Rs 100.42 crore registered in the year ago period. For the financial year ending March 31,2025 the total income was at Rs 402.24 crore.
Commenting on the financial performance, Dr Agarwal's Health Care Ltd, CEO Dr Adil Agarwal said, "the first quarter of the new fiscal year has started with a robust performance."
"We are pleased to report the highest-ever revenue on a quarterly basis, with profit margins sustaining at high levels. Total income for the quarter stood at Rs 501 crore, a growth of 22.3 per cent over the same period of last year driven by healthy growth across our network," he said.
Agarwal said, "Operationally, our network grew to 249 eye care facilities as of June 30, 2025, with 13 additions during the quarter. We also marked our strategic entry into the Delhi market, opening our first centre in the capital to strengthen our presence in North India."
"We remain committed to expanding our footprint, investing in advanced technologies, and delivering superior clinical outcomes to our patients," he said.
During the April-June 2025 quarter, Dr Agarwal's Health added 1 tertiary, 7 secondary and 5 primary care facilities. It performed 78,882 surgeries during the quarter under review, up by 16 per cent year-on-year basis.
The sales of services during the quarter under review contributed 78.6 per cent, while sale of products accounted for 21.4 per cent to the revenue from operations.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
MORE NEWS
Trai Recommends 6 GHz, E, V Band Allocation
Trai suggests administrative allocation of 6 GHz, E, and V bands for telecom backhaul....
TotalEnergies Sells Stake in Adani Green Energy
TotalEnergies sells 1.74% stake in Adani Green Energy for Rs 2,778 cr. Stake reduced to...
TCS Acquires Coastal Cloud for $700 Million
TCS acquires Coastal Cloud for USD 700 million, strengthening its Salesforce and AI...
JSW Paints Acquires AkzoNobel India Stake
JSW Paints completes acquisition of majority stake in AkzoNobel India, becoming the...
Park Medi World IPO Subscribed 52% on Day 1
Park Medi World''s IPO received 52% subscription on day 1. The Rs 920-crore IPO closes...
Dasnac Invests Rs 2,000 Cr in Noida Luxury Housing
Dasnac to invest Rs 2,000 crore in a luxury housing project, Dasnac Westminster, in...
Nephrocare IPO Subscribed 12% on Day 1
Nephrocare Health Services IPO received 12% subscription on day 1. IPO details, price...
Wakefit IPO Subscribed Over 2 Times
Wakefit''s Rs 1,289-cr IPO was subscribed over 2 times on the final day. Details on...
IAN Group to Deploy USD 100M Alpha Fund by 2027
IAN Group to deploy its USD 100 million IAN Alpha Fund in early-stage startups by 2027....
Corona Remedies IPO Subscribed 137 Times
Corona Remedies IPO subscribed 137.04 times on final day. QIBs subscribed 278.52 times,...
Read More »